ICD-10-CM Billable Code

H35.719

Central serous chorioretinopathy, unspecified eye

Clinical Classification Guidelines

Medical Intelligence & Overview

Central serous chorioretinopathy (CSC) is an eye condition that affects the retina, the light-sensitive layer at the back of your eye. It involves the buildup of fluid under the retina, which can cause visual disturbances. When it occurs in one eye without a specific cause, it is classified under the ICD-10 code H35.719. Although it can resolve on its own, understanding the symptoms, causes, and management options is helpful for those affected.

Causes & Symptoms

Clinical Causes: The exact cause of central serous chorioretinopathy is not fully understood, but several factors appear to contribute: - Stress and emotional distress - Use of corticosteroid medications, including oral steroids and topical or inhaled forms - Hormonal imbalances - Type A personality traits, such as competitiveness and high-stress lifestyles - Smoking - Hypertension (high blood pressure) - Sleep disturbances - Exposure to intense light or UV rays in some cases These factors may lead to increased pressure in the choroid layer (a layer of blood vessels behind the retina), resulting in fluid leakage and accumulation beneath the retina.

Key Symptoms: Many individuals with central serous chorioretinopathy experience the following symptoms: - Sudden onset of blurred or distorted vision - A dark or gray area in the central vision - Seeing a relative scotoma (a blind spot) - Colors appearing faded or less vibrant - Retinal detachment in some cases, leading to more significant vision loss - Flashes of light or visual disturbances in rare instances Symptoms often develop over days to weeks and may resolve spontaneously, although in some cases, they can persist or recur.

Diagnostic & Treatment

Diagnosis Path: Diagnosing CSC involves a comprehensive eye examination combined with specialized imaging tests: - **Fundus examination:** A detailed inspection of the retina using an ophthalmoscope - **Optical coherence tomography (OCT):** Provides high-resolution cross-sectional images of the retina, revealing fluid accumulation - **Fluorescein angiography:** Injects a dye into your arm to visualize blood flow in the retina and choroid, identifying leaks - **Indocyanine green angiography:** Offers additional detail of the choroidal vessels These procedures help differentiate CSC from other eye conditions and assess the extent of fluid buildup.

Treatment Protocols: While some cases of central serous chorioretinopathy resolve on their own within a few months, treatment options are available if symptoms persist or recur: - **Observation:** Monitoring the condition over time, especially if vision is mildly affected - **Photodynamic therapy (PDT):** Uses laser treatment in combination with a light-sensitive drug to close leaking blood vessels - **Laser photocoagulation:** Targeted laser burns to seal leaks, primarily in localized cases - **Medications:** Some drugs may be prescribed to reduce fluid leakage, though their effectiveness varies - **Addressing underlying factors:** Managing stress, controlling blood pressure, and avoiding corticosteroids when possible It is important to consult with an eye care professional for personalized assessment and management options.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H35.719 a billable ICD-10 code?
Yes, H35.719 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H35.719?
Clinical documentation must specify the nature of Central serous chorioretinopathy, unspecified eye and any associated comorbidities for accurate reporting.

Cite this Clinical Reference